United States Biotechnology & Medical Research

eXoZymes Inc (EXOZ)

Track

Track

Over the past ninety days, eXoZymes Inc. recorded five purchase transactions totaling 6,405.17 USD. Chief Executive Officer Michael Heltzen exclusively executed these acquisitions. This activity follows a period where the stock price declined by 29.1 percent. No sales occurred during this timeframe, preceding the upcoming November 2026 results report.
Ticker: EXOZ Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for eXoZymes Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
261.32
Quantity 3,202 +10.7%
Value US$3,986,365
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
498.89
Quantity 4,882 -29.7%
Value US$415,913
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
23.76
Quantity 15,858 +46.6%
Value US$3,259,435
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
7.50
Quantity 100 +0.7%
Value US$750
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
7.52
Quantity 250 +1.8%
Value US$1,880
3.4
Korman Tyler Paz Chief Scientific Officer Officer
Transaction date
Sale
Price
10.53
Quantity 750 -0.1%
Value US$7,894
3.4
Korman Tyler Paz Chief Scientific Officer Officer
Transaction date
Sale
Price
10.04
Quantity 750 -0.1%
Value US$7,530
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
10.22
Quantity 1,040 +10.8%
Value US$10,629
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
10.78
Quantity 1,767 +83.9%
Value US$19,048
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
10.72
Quantity 121 +6.1%
Value US$1,297
3.9
Heltzen Michael Chief Executive Officer Officer
Transaction date
Purchase
Price
11.10
Quantity 1,984 +inf%
Value US$22,022
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-02 2026-08-26 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
3,202 +10.7%
261.32
US$3,986,365 		3,202 +10.7% 261.32 US$3,986,365
2026-09-02 2026-08-26 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
4,882 -29.7%
498.89
US$415,913 		4,882 -29.7% 498.89 US$415,913
2026-09-02 2026-08-26 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
15,858 +46.6%
23.76
US$3,259,435 		15,858 +46.6% 23.76 US$3,259,435
2026-09-02 2026-08-25 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
100 +0.7%
7.50
US$750 		100 +0.7% 7.50 US$750
2026-09-02 2026-08-25 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
250 +1.8%
7.52
US$1,880 		250 +1.8% 7.52 US$1,880
2026-04-10 2026-04-09 S Sale
3.4
Korman Tyler Paz

Chief Scientific Officer

Officer
750 -0.1%
10.53
US$7,894 		750 -0.1% 10.53 US$7,894
2026-04-10 2026-04-08 S Sale
3.4
Korman Tyler Paz

Chief Scientific Officer

Officer
750 -0.1%
10.04
US$7,530 		750 -0.1% 10.04 US$7,530
2025-07-02 2025-07-02 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
1,040 +10.8%
10.22
US$10,629 		1,040 +10.8% 10.22 US$10,629
2025-01-21 2025-01-17 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
1,767 +83.9%
10.78
US$19,048 		1,767 +83.9% 10.78 US$19,048
2025-01-21 2025-01-16 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
121 +6.1%
10.72
US$1,297 		121 +6.1% 10.72 US$1,297
2024-11-19 2024-11-15 B Purchase
3.9
Heltzen Michael

Chief Executive Officer

Officer
1,984 +inf%
11.10
US$22,022 		1,984 +inf% 11.10 US$22,022
Explore more

More insider trading research around eXoZymes Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America